Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)

Related Experiment Video

Updated: Jul 11, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

Peter C Appelbaum1

  • 1Hershey Medical Center, P.O. Box 850, Hershey, PA 17033, USA. pappelbaum@psu.edu

International Journal of Antimicrobial Agents
|September 25, 2007
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly showing reduced susceptibility to vancomycin, a key antibiotic. Accurate detection and infection control are crucial for managing these challenging infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Antimicrobial Resistance

Background:

  • Vancomycin is the primary treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections.
  • Increased vancomycin use has led to the emergence of MRSA with reduced susceptibility.
  • Vancomycin-intermediate S. aureus (VISA), heterogeneous VISA (hVISA), and vancomycin-resistant S. aureus (VRSA) are emerging phenotypes.

Purpose of the Study:

  • To highlight the growing problem of vancomycin-non-susceptible MRSA.
  • To discuss the challenges in detecting these resistant strains.
  • To emphasize the need for improved management strategies.

Main Methods:

  • Review of current definitions for VISA, hVISA, and VRSA.
  • Discussion of the limitations of routine susceptibility testing.
  • Analysis of patient risk factors and transmission pathways.

Main Results:

  • Detection of vancomycin non-susceptibility in MRSA is often unreliable and underreported.
  • Reduced vancomycin susceptibility is associated with clinical treatment failures.
  • Patients with prior vancomycin exposure are at higher risk.

Conclusions:

  • Accurate susceptibility testing for MRSA is essential, especially in treatment failures.
  • Limited treatment options exist for infections caused by vancomycin-non-susceptible MRSA.
  • Prompt identification, isolation, and infection control are critical to prevent spread.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...